Holen Sie sich die Stockscreener-App
13.03
4.20%
0.525
Schlusskurs vom Vortag:
$12.50
Offen:
$12.81
24-Stunden-Volumen:
522.60K
Relative Volume:
0.43
Marktkapitalisierung:
$959.48M
Einnahmen:
$193.35M
Nettoeinkommen (Verlust:
$-177.58M
KGV:
-5.3163
EPS:
-2.45
Netto-Cashflow:
$-172.43M
1W Leistung:
+10.38%
1M Leistung:
-2.51%
6M Leistung:
-31.34%
1J Leistung:
-38.21%
1-Tages-Spanne:
$12.59
$13.10
1-Wochen-Bereich:
$11.43
$13.36
52-Wochen-Spanne:
$11.11
$27.63
Schrodinger Inc Stock (SDGR) Company Profile
Firmenname
Schrodinger Inc
Sektor
Branche
Telefon
503-299-1150
Adresse
1540 BROADWAY, NEW YORK, NY
Compare SDGR vs VEEV, TEM, BTSG, HQY, WAY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SDGR
Schrodinger Inc
|
13.03 | 920.81M | 193.35M | -177.58M | -172.43M | -2.45 |
|
VEEV
Veeva Systems Inc
|
185.73 | 30.56B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
52.05 | 9.19B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
41.70 | 7.33B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
82.25 | 6.87B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
26.57 | 5.09B | 906.14M | -52.62M | 89.62M | -0.3621 |
Schrodinger Inc Stock (SDGR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-15 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-09-30 | Eingeleitet | Goldman | Neutral |
| 2025-08-15 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-08-14 | Eingeleitet | Barclays | Overweight |
| 2025-07-03 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2024-07-02 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-05 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2023-05-05 | Fortgesetzt | Piper Sandler | Overweight |
| 2022-12-19 | Eingeleitet | Goldman | Neutral |
| 2022-03-01 | Eingeleitet | Citigroup | Buy |
| 2021-11-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-19 | Eingeleitet | Piper Sandler | Overweight |
| 2021-11-11 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-10-13 | Eingeleitet | Berenberg | Buy |
| 2021-09-01 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-05-25 | Eingeleitet | Craig Hallum | Buy |
| 2020-11-23 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-10-12 | Hochstufung | Jefferies | Hold → Buy |
| 2020-03-02 | Eingeleitet | BMO Capital Markets | Outperform |
| 2020-03-02 | Eingeleitet | Jefferies | Hold |
| 2020-03-02 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Schrodinger Inc Aktie (SDGR) Neueste Nachrichten
[144] Schrodinger, Inc. SEC Filing - Stock Titan
Vanguard Group Inc. Has $127.16 Million Holdings in Schrodinger, Inc. $SDGR - MarketBeat
Schrodinger (NASDAQ: SDGR) CEO gets options, sells shares under 10b5-1 - Stock Titan
Schrodinger (SDGR) CFO receives new stock options and RSU grants - Stock Titan
Schrodinger (NASDAQ: SDGR) EVP granted stock options and RSU awards - Stock Titan
Schrodinger (NASDAQ: SDGR) CTO Lorton receives new stock and option awards - Stock Titan
Schrodinger (SDGR) CAO Jenny Herman receives new RSU and option awards - Stock Titan
Schrodinger (SDGR) executive granted 48,500 options and sells shares for taxes - Stock Titan
Equity grants to Schrodinger (NASDAQ: SDGR) officer include options and RSUs - Stock Titan
Schrodinger (SDGR) executive receives new RSUs and stock option grant - Stock Titan
Schrodinger, Inc. (SDGR) Stock Analysis: Investors Eye a Potential 93% Upside Amid Market Turbulence - DirectorsTalk Interviews
Schrodinger, Inc. (NASDAQ:SDGR) Given Average Rating of "Hold" by Brokerages - MarketBeat
Schrödinger, Inc. (SDGR) Transition to Licensing Model Triggers Robust Revenue Growth - Insider Monkey
Schrodinger, Inc. (SDGR) Transition to Licensing Model Triggers Robust Revenue Growth - Bitget
Schrödinger (SDGR) Valuation After 2025 Results And Shift To Hosted Licensing Model - simplywall.st
Assessing Schrödinger (SDGR) Valuation After Full Year 2025 Earnings And AI Platform Progress - Yahoo Finance
Does Schrödinger’s 2025 Revenue Surge And Narrower Loss Reshape The Bull Case For SDGR? - simplywall.st
SDGR Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Analysts Offer Insights on Healthcare Companies: Schrodinger (SDGR), Medline, Inc. Class A (MDLN) and Silence Therapeutics (SLN) - The Globe and Mail
Schrodinger Inc. (SDGR) Stock Falls on Q4 2025 Earnings - Quiver Quantitative
Schrodinger (NASDAQ:SDGR) Shares Gap Up on Better-Than-Expected Earnings - MarketBeat
Schrödinger, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:SDGR) 2026-02-26 - Seeking Alpha
Schrodinger Q4 Earnings Call Highlights - MarketBeat
Schrodinger Inc (SDGR) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid Transition Challenges - GuruFocus
Schrödinger (SDGR) Reports Strong 2025 Revenue Growth and Strate - GuruFocus
Earnings Call Summary | Schrodinger(SDGR.US) Q4 2025 Earnings Conference - 富途牛牛
Schrodinger (NASDAQ:SDGR) Announces Quarterly Earnings Results, Beats Estimates By $0.57 EPS - MarketBeat
Schrodinger Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Schrödinger Reports Fourth Quarter and Full-Year 2025 Financial Results - PharmiWeb.com
Earnings call transcript: Schrödinger Q4 2025 revenue beats forecast, shares rise - Investing.com
Schrödinger, Inc. (SDGR) Stock Analysis: Unveiling a 126.78% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Schrödinger to Participate in Upcoming March 2026 Investor Conferences - BioSpace
Earnings Preview For Schrodinger - Benzinga
Schrödinger to Participate in Upcoming Investor Conferences - PharmiWeb.com
Schrodinger (NASDAQ:SDGR) Reaches New 52-Week LowShould You Sell? - MarketBeat
SDGR Technical Analysis & ETF Price Forecast - Intellectia AI
Schrödinger, Inc. Hits New 52-Week Low at USD 11.11 - Markets Mojo
Schrodinger's Pivotal Earnings Report Approaches () - aktiencheck.de
Jupiter Asset Management Ltd. Acquires Shares of 234,625 Schrodinger, Inc. $SDGR - MarketBeat
Top 3 health care stocks that could lead to your biggest gains in Q1 - MSN
Top 3 Health Care stocks That Could Lead To Your Biggest Gains In Q1 - Fidelity
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - PharmiWeb.com
Schrodinger (SDGR) Projected to Post Earnings on Wednesday - MarketBeat
Schrodinger, Inc. (SDGR) Investor Outlook: Unpacking A 123% Potential Upside - DirectorsTalk Interviews
How (SDGR) Movements Inform Risk Allocation Models - Stock Traders Daily
Schrodinger (NASDAQ:SDGR) CAO Sells $10,370.08 in Stock - MarketBeat
Schrodinger to Announce Fourth Quarter and Full-Year 2025 Financial Results on February 25 - marketscreener.com
Schrodinger stock hits 52-week low at 12.8 USD By Investing.com - Investing.com Canada
Schrodinger (NASDAQ:SDGR) EVP Sells $10,708.80 in Stock - MarketBeat
Schrödinger to Announce Fourth Quarter and Full-Year 2025 Financial Results on February 25 - BioSpace
Press Release: Schrödinger to Announce Fourth Quarter and Full-Year 2025 Financial Results on February 25 - 富途牛牛
Finanzdaten der Schrodinger Inc-Aktie (SDGR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.87%
0.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):